FDA Alert
FDA Alert
08/19/2024
Anthony Calabro, MA
The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.
08/19/2024
allergy
allergy
06/26/2019
The FDA has approved the first treatment option for chronic, inadequately controlled rhinosinusitis with nasal polyps.
06/26/2019